Search
ASP Isotopes Inc
ASPIAdd to Watchlist
5.630USD
-0.540-8.75%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
708.84MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-8.75%
5 Days
-8.75%
1 Month
-29.36%
6 Months
0.00%
Year to Date
+5.23%
1 Year
-19.34%
Key Figures
6.160Open
6.500High
4.85MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
3.85%Turnover Ratio
6.170Prev. Close
5.550Low
20.22MTurnover
LossP/E Static
2.45P/B
0.00%Div Yield TTM
-52.49%ROA
14.49052wk High
1.60Volume Ratio
-35.11MNet Profit
125.90MShares
-2.0445EPS TTM
3.41Beta
-116.50%ROE
3.92052wk Low
15.40%Amplitude
39.86%Gross Margin
708.84MMarket Cap
-3.88Reward/Risk
5.81%Risk Rate
TradingKey Stock Score of ASP Isotopes Inc
Currency: USD Updated: 2026-07-02Key Insights
ASP Isotopes Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 89 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 13.00.In the medium term, the stock price is expected to trend up.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
ASP Isotopes Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
ASP Isotopes Inc Highlights
StrengthsRisks
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 5407.52% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 23.85M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 23.85M.
Overvalued
The company’s latest PE is -2.75, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 73.95M shares, increasing 13.33% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 18.33K shares of this stock.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
13.000
Target Price
+110.70%
Upside Space
ASP Isotopes Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
ASP Isotopes Inc Info
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Ticker SymbolASPI
CompanyASP Isotopes Inc
CEOAinscow (Robert)
Websitehttps://aspisotopes.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of ASP Isotopes Inc (ASPI)?
The current price of ASP Isotopes Inc (ASPI) is 5.63.
What is the symbol of ASP Isotopes Inc?
The ticker symbol of ASP Isotopes Inc is ASPI.
What is the 52-week high of ASP Isotopes Inc?
The 52-week high of ASP Isotopes Inc is 14.49.
What is the 52-week low of ASP Isotopes Inc?
The 52-week low of ASP Isotopes Inc is 3.92.
What is the market capitalization of ASP Isotopes Inc?
The market capitalization of ASP Isotopes Inc is 708.84M.
Is ASP Isotopes Inc (ASPI) currently rated as Buy, Hold, or Sell?
According to analysts, ASP Isotopes Inc (ASPI) has an overall rating of Buy, with a price target of 13.00.
What is the Earnings Per Share (EPS TTM) of ASP Isotopes Inc (ASPI)?
The Earnings Per Share (EPS TTM) of ASP Isotopes Inc (ASPI) is -2.11.